News
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
Shares in the maker of Ozempic crashed to three-year low after the pharma giant warned its injections were losing ground to ...
A major Alzheimer’s disease medical group is recommending that specialists may use certain blood tests to help diagnose ...
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.3% in the morning session after its key competitor in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results